Reese Pharmaceutical Company OTC Products Recalled because they were Mislabeled as Guaifenesin Tablets
Pharmacists and Consumers are informed by the FDA that Reese Pharmaceutical Company OTC Products are recalled because they were mislabeled as Guaifenesin tablets posing a threat of overdose to patients. Background of Reese Pharmaceutical Company OTC Products Refenesen Expectorant (guaifenesin 200 mg tablets), Select Brand Mucus Relief Expectorant (guaifenesin 200 mg), QC Medifin Expectorant (guaifenesin [...]
Read more
Recent Comments